UniSuper Management Pty Ltd Increases Stock Holdings in Humana Inc. (NYSE:HUM)

UniSuper Management Pty Ltd boosted its position in shares of Humana Inc. (NYSE:HUM) by 32.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 11,227 shares of the insurance provider’s stock after purchasing an additional 2,770 shares during the period. UniSuper Management Pty Ltd’s holdings in Humana were worth $2,848,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of HUM. Vanguard Group Inc. raised its position in shares of Humana by 15.8% during the 4th quarter. Vanguard Group Inc. now owns 12,829,210 shares of the insurance provider’s stock valued at $3,254,899,000 after buying an additional 1,751,857 shares during the period. Pzena Investment Management LLC raised its position in Humana by 44.0% in the fourth quarter. Pzena Investment Management LLC now owns 3,609,382 shares of the insurance provider’s stock valued at $915,736,000 after purchasing an additional 1,103,132 shares during the period. Boston Partners lifted its stake in shares of Humana by 435.8% in the 4th quarter. Boston Partners now owns 1,098,702 shares of the insurance provider’s stock valued at $279,236,000 after purchasing an additional 893,637 shares during the last quarter. Artisan Partners Limited Partnership grew its holdings in shares of Humana by 83.4% during the 4th quarter. Artisan Partners Limited Partnership now owns 673,715 shares of the insurance provider’s stock worth $170,928,000 after purchasing an additional 306,433 shares during the period. Finally, Retirement Systems of Alabama increased its position in shares of Humana by 735.9% during the 4th quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider’s stock worth $55,563,000 after purchasing an additional 192,801 shares during the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research analysts have commented on the stock. Piper Sandler upped their target price on shares of Humana from $270.00 to $288.00 and gave the company a “neutral” rating in a research report on Wednesday, January 15th. Morgan Stanley lowered their price objective on shares of Humana from $301.00 to $285.00 and set an “equal weight” rating for the company in a research report on Wednesday, February 12th. Royal Bank of Canada reiterated an “outperform” rating and issued a $283.00 target price on shares of Humana in a report on Wednesday, February 12th. Truist Financial upped their price target on Humana from $260.00 to $290.00 and gave the stock a “hold” rating in a research note on Monday, January 6th. Finally, JPMorgan Chase & Co. dropped their price objective on Humana from $257.00 to $256.00 and set a “neutral” rating for the company in a research note on Tuesday, February 18th. Eighteen research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat, Humana currently has an average rating of “Hold” and an average price target of $285.68.

Humana Stock Performance

Shares of Humana stock opened at $263.95 on Friday. The firm’s fifty day simple moving average is $270.14 and its 200-day simple moving average is $273.87. Humana Inc. has a 12 month low of $213.31 and a 12 month high of $406.46. The stock has a market capitalization of $31.86 billion, a price-to-earnings ratio of 26.53, a PEG ratio of 2.05 and a beta of 0.57. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76.

Humana (NYSE:HUM) last posted its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, beating analysts’ consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. As a group, equities analysts forecast that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be given a dividend of $0.885 per share. The ex-dividend date is Friday, March 28th. This represents a $3.54 dividend on an annualized basis and a yield of 1.34%. Humana’s payout ratio is 35.58%.

Insider Buying and Selling at Humana

In related news, insider Timothy S. Huval sold 3,703 shares of the stock in a transaction on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total transaction of $948,930.78. Following the completion of the sale, the insider now directly owns 8,181 shares of the company’s stock, valued at $2,096,463.06. This trade represents a 31.16 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 0.37% of the company’s stock.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.